Catalyst

Slingshot members are tracking this event:

TG Therapeutics (TGTX) Announces Positive DSMB Recommendation for Continuation of the UNITY-CLL Phase 3 Trial

Source Link:
http://ir.tgtherapeutics.com/releasedetail.cfm?ReleaseID=1000714

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TGTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details The independent Data Safety Monitoring Board (DSMB) providing oversight for the UNITY-CLL Phase 3 trial reviewed the cumulative safety data from the ongoing clinical study and informed the Company that it has identified no safety concerns, and recommended the continuation of the study with no modifications.
http://ir.tgtherapeu...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Nov 22, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Unity-cll Program, Dsmb Recommendation
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.